United States Generic Drugs Market to Grow with a CAGR of 7.46% through 2028
Easy availability and affordability of the product
and presence of patent cliffs is expected to drive the United States Generic
Drugs Market growth in the forecast period, 2024-2028.
According to
TechSci Research report, “United States Generic Drugs Market –Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2018-2028F”,
the United States Generic Drugs Market stood at USD 104.23 Billion in 2022 and is
anticipated to project steady growth in the forecast period with a CAGR of 7.46%
through 2028. The United States generic drugs market is driven by several
influential factors. Primarily, the expiration of branded drug patents opens
the market for generic counterparts, allowing for increased competition and
lower prices.
Additionally, the
need to reduce healthcare costs promotes the use of cost-effective generic
drugs. Government initiatives and regulations also play a pivotal role in
encouraging the use and production of generic drugs. The growing aging
population, who typically require more medication, further fuels the demand for
affordable generic medicines.
The United
States Generic Drugs Market is a thriving and ever-evolving industry that plays
a vital role in the healthcare ecosystem. With its focus on affordability,
accessibility, and quality, it continues to shape and revolutionize the way
healthcare is delivered. In this market,
encompassing the manufacturing, distribution, and sale of generic medications
within the United States, pharmaceutical drugs are carefully formulated to be
identical to their brand-name counterparts. They are rigorously tested and meet
stringent regulatory standards in terms of dosage form, safety, strength, route
of administration, quality, and performance characteristics. This ensures that
patients receive medications that are not only cost-effective but also deliver
the same therapeutic benefits as their brand-name counterparts.
One significant
aspect of the United States Generic Drugs Market is that these generic drugs
enter the market only after the expiration of patent protection for their
brand-name counterparts. This allows other companies to offer them at
significantly lower prices, making healthcare more accessible and
cost-effective for the public. By providing affordable medication options, the
market caters to the healthcare needs of countless individuals, ensuring that
they can receive the necessary treatment without facing exorbitant costs.
In fact, as of
2021, generic drugs account for more than 80% of all prescriptions filled in
the United States. This substantial market share highlights their immense
popularity and impact on the healthcare landscape. It speaks to the trust and
confidence placed in generic drugs by healthcare professionals and patients
alike, who recognize their effectiveness and affordability.
Moreover, the
United States Generic Drugs Market empowers individuals to manage their health
effectively while reducing the financial burden associated with healthcare
expenses. By providing a wide range of medication options, it gives patients
the freedom to choose what works best for them, ensuring that they can receive
the treatment they need without compromising on quality or breaking the bank.
This patient-centric approach fosters a more inclusive healthcare system and
promotes better health outcomes for all.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States Generic Drugs Market.”
The United
States Generic Drugs Market is a dynamic and essential component of the
healthcare system. Its commitment to delivering high-quality, affordable
medications has transformed healthcare accessibility, making it possible for
individuals to receive the treatment they need without compromising on quality
or financial stability. As the market continues to evolve, it will undoubtedly
play a pivotal role in shaping the future of healthcare, ensuring that everyone
has access to affordable and effective medications.
The United
States Generic Drugs Market is segmented into type, application, mode of
delivery, form, source, distribution channel, regional distribution, and
company.
Based on distribution
channel, it is anticipated that retail pharmacies will continue to dominate the
Generic Drugs Market in the United States. This can be primarily attributed to
their extensive and widespread presence, ensuring convenient accessibility for
the general public across various regions and communities. The strategic
locations of these retail pharmacies, whether in urban centers or rural areas,
allow for easy and prompt access to a wide range of generic drugs. Furthermore,
the increasing trend of purchasing over-the-counter drugs further reinforces
the stronghold of retail pharmacies in the market. With the convenience of
self-selection and immediate availability, consumers are increasingly opting to
purchase common medications directly from these pharmacies. This shift in
consumer behavior has not only contributed to the sustained dominance of retail
pharmacies but has also driven their continuous growth in the Generic Drugs
Market.
Moreover, the
growing trust placed in the expert advice provided by pharmacists at these
retail pharmacies is a significant contributing factor to their projected
dominance. Pharmacists, with their extensive knowledge and expertise, play a
crucial role in guiding patients and consumers in choosing the right generic
drugs for their needs. This personalized care and professional guidance not
only enhances the customer experience but also fosters a sense of trust and
reliability, solidifying the position of retail pharmacies as the go-to
destination for generic drugs. Through their reliable services, extensive
accessibility, and personalized care, retail pharmacies are well-positioned to
maintain their prominent role in the United States Generic Drugs Market. Their
continued dominance is a testament to the convenience, expertise, and trust
that they offer to the general public, ensuring the availability and
affordability of generic drugs for all.
Based on region,
the Midwest region of the United States has long been a dominant force in the
generic drugs market, and this can be attributed to a multitude of factors that
contribute to its success. One key reason for its prominence is the high
concentration of pharmaceutical manufacturing facilities found in the region.
Thanks to the Midwest's rich industrial heritage and robust infrastructure,
pharmaceutical companies have been attracted to establish their operations
here, leading to a strong manufacturing presence. Moreover, the Midwest boasts
several renowned biomedical research institutions that play a pivotal role in
driving innovation in the field of generic drugs. These institutions serve as
hubs for groundbreaking research and development, fostering a culture of
innovation and pushing the boundaries of what is possible in the realm of
generic drugs. The continuous collaboration between these institutions and
pharmaceutical companies in the region has facilitated the development of
cutting-edge drugs that meet the needs of patients across the United States.
Additionally,
the geographical location of the Midwest offers a significant logistical
advantage. Situated in the heart of the United States, the region serves as a
strategic hub for distributing generic drugs across the country. This central
location not only enables efficient transportation and distribution of products
but also facilitates timely access to various markets and healthcare facilities
throughout the nation. The Midwest's accessibility and connectivity make it a preferred
choice for pharmaceutical companies looking to reach a wide customer base
efficiently. The Midwest's dominance in the generic drugs market can be
attributed to a combination of factors, including its robust manufacturing
infrastructure, renowned research institutions, and strategic geographical
location. This convergence of strengths has established the region as a
powerhouse in the field, with a significant impact on the availability and
accessibility of generic drugs across the United States. The Midwest continues
to be at the forefront of innovation, driving advancements in the generic drugs
market and improving healthcare outcomes for patients nationwide.
Major companies
operating in the United States Generic Drugs Market are:
- Teva Pharmaceuticals USA, Inc.
- Pfizer Inc.
- Sandoz US
- Endo International plc
- Aurobindo Pharma USA, Inc.
- Abbott Laboratories Inc.
- Eli Lilly and Company
- Sun Pharma USA
- Lupin Pharmaceuticals, Inc.
- Zydus Pharmaceuticals USA
Download Free Sample Report
Customers can
also request 10% free customization on this report.
“The future of
the United States Generic Drugs Market appears promising. As patent protections
on brand-name drugs expire, generics will continue to gain traction, offering
affordable alternatives to patients and healthcare providers. Additionally, the
ongoing emphasis on cost reduction in healthcare is likely to drive further
demand for generic drugs. Moreover, government policies favoring generics and
increased acceptance among consumers due to their cost-effectiveness and
similar efficacy as the branded drugs are likely to fuel the market growth. The
availability of a wide range of generic drug options across various therapeutic
areas and the growing adoption of generic drugs by healthcare professionals
also contribute to the positive outlook of the market. The United States
Generic Drugs Market is expected to continue its growth trajectory in the
coming years, driven by factors such as increasing demand for cost-effective
medications, favorable government policies, and the need for affordable
healthcare solutions.,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“United
States Generic Drugs Market
By Type (Small Molecule Generics, Biosimilars), By
Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious
Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral,
Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House,
Contract Manufacturing Organizations), By Distribution Channel (Hospital
Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region,
Competition, Forecast and& Opportunities, 2018-2028F”,
has evaluated the future growth potential of United States Generic Drugs Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United States Generic Drugs Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com